Company: LIMN
Filing Date: 2025-08-15
Form Type: NT 10-Q
Source: 0001104659-25-078852
Chunk: 2

Company: Liminatus Pharma, Inc.
Filing Date: 2025-08-15
Form: NT 10-Q
Chunk 2
---
 executive
officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed
or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an
executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.

|                                                                                                             | ATTENTION |
| Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001). |           |